Anzeige
❌
Mehr »
Mittwoch, 11.11.2026 - Börsentäglich über 12.000 News
Nach dem KI-Boom kommt Quantum: Warum Anleger jetzt auf Delta Gold schauen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
XM

WKN: A2JDJS | ISIN: US98420P3082 | Ticker-Symbol: XMS
Frankfurt
11.11.26 | 08:07
0,242 Euro
-0,82 % -0,002
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
XTANT MEDICAL HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
XTANT MEDICAL HOLDINGS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,2400,25410:03
0,2420,25210:00

Aktuelle News zur XTANT MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
02.09.Lucid Capital initiates Xtant Medical stock with buy rating1
11.08.Xtant Medical auf der Canaccord Genuity Konferenz: Wachstumsplan setzt auf Biologika2
11.08.Xtant outlines $99M-$103M 2026 revenue guidance while integrating Dilon sales force2
11.08.Xtant Medical misses top-line and bottom-line estimates; lowers FY2026 outlook1
11.08.Xtant Medical Holdings, Inc. - 10-Q, Quarterly Report2
11.08.Xtant Medical Holdings, Inc.: Xtant Medical Reports Second Quarter 2026 Financial Results348Launched Trivium Shaped, an extension of its Trivium line of premium, next-generation demineralized bone matrix allograft for bone grafting procedures Company to...
► Artikel lesen
07.08.Xtant Medical Holdings, Inc. - 8-K, Current Report2
13.05.Xtant Medical Holdings, Inc.: Xtant Medical Reports First Quarter 2026 Financial Results939Raises full-year 2026 revenue guidance to a range of $101-$105 million Significantly strengthens balance sheet Enters into exclusive U.S. distribution agreement...
► Artikel lesen
XTANT MEDICAL Aktie jetzt für 0€ handeln
31.03.Xtant Medical Holdings, Inc.: Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results279Full year 2025 revenue totals $133.9 million, an increase of 14% year-over-year Xtant delivers positive net income, adjusted EBITDA and operating cash flow Total...
► Artikel lesen
11.12.25Xtant Medical Holdings, Inc.: Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata Synthetic Bone Graft301nanOss Strata is designed to more closely mimic the structure of human bone, increase the graft's surface area, improve osteoconductivity and enhance the stimulation...
► Artikel lesen
01.12.25Companion Spine LLC Completes Acquisition of the Business and Assets of Paradigm Spine GmbH, including the Coflex and CoFix Spine Implants and All Other Implant Systems, from Xtant Medical Holdings, Inc.637Companion Spine is the first company in the world with a product portfolio solely focused on Total Disease State Solutions ("TDS") for degenerative spine diseases. This acquisition creates...
► Artikel lesen
01.12.25Xtant Medical Holdings, Inc.: Xtant Medical Completes Sale of its Coflex Assets and Paradigm OUS Businesses to Companion Spine270BELGRADE, Mont., Dec. 1, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1